FGL1 and metabolic dysfunction-associated steatotic liver disease: NAFLD subjects had a significantly higher serum FGL1 level than those without NAFLD (7699.7 ± 194.9 vs. 6112.3 ± 143.7 lg/ml; p <0.001) 22.